Danese S, Colombel JF, Lukas M, Gisbert JP, et al. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. Lancet Gastroenterol Hepatol 2021 Nov 16. pii: S2468-1253(21)00294.
PMID: 34798038